InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Mutz Christopher, Responsable. Officer active across 1 companies, notably ANI Pharmaceuticals INC. Aggregated, 5 filings have been published. Total volume traded: €706k. The latest transaction was filed on 20 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
US$352,8735,323 shares@ US$66.2920.020% mcap100.0% of flow
Common Stock
SEC:0001846487-26-000006·
€352,8735,323 shares@ €66.2920.020% mcap47.2% of flow
Common Stock
SEC:0001846487-26-000006:0·
06,476 shares0
Common Stock
SEC:0001415889-22-004411:0·
019,428 shares0
Common Stock
SEC:0001415889-22-003396:0·
€42,1501,184 shares@ €35.59950.0024% mcap5.6% of flow
Common Stock
SEC:0001415889-22-001535:0·
5 of 5 declarations
About Mutz Christopher
Christopher Mutz is the Head of Rare Disease at ANI PHARMACEUTICALS INC. His role is to lead initiatives related to rare diseases, focusing on innovation and treatment development. His expertise is essential for the success of the organization.
